cinitapride

Cinitapride is indicated for the treatment of gastrointestinal disorders associated with motility disturbances such as gastroesophageal reflux disease, non-ulcer dyspepsia and delayed gastric emptying. It is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in India, Mexico, Pakistan and Spain.. Reference standards of Cinitapride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Cinitapride - API Standards 
    [catalogue_number] => PA 30 54000
    [category_ids] => ,103,79,80,71,78,70,82,
    [chemical_name] => 
    [weight] => 402.49
    [form] => C21H30N4O4
    [cas] => 66564-14-5
    [pslug] => 66564-14-5-cinitapride-api-pa3054000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)